Skip to main content
Erschienen in: Diabetology International 2/2024

22.09.2023 | Original Article

Practice of complementary and alternative medicine use in North Indian children with type 1 diabetes: an exploratory study

verfasst von: Priyanka Walia, Latika Rohilla, Devi Dayal

Erschienen in: Diabetology International | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Intermittent or concurrent use of Complementary and Alternative medicines (CAM) with insulin may have adverse effects in children with Type 1 Diabetes (T1DM). This study explores the practices of CAM use in children with T1DM.

Methods

An exploratory study was conducted among parents of children with T1DM attending a tertiary-level diabetes clinic. Data were collected using a structured pre-tested questionnaire.

Results

Two-hundred parents were invited; 183 (91.5%) completed the study. The mean age of the children was lower among CAM users than others (7.9 ± 4.3 vs 9.3 ± 4.3 years, p 0.032). The two groups were similar in gender, family income, parental education, and age at diagnosis. Sixty-seven (36.6%) had used CAM. The parents’ reasoning for CAM use was to cure diabetes (62.7%), to improve glycemic control (28.3%), or considering it harmless (17.9%). The most commonly used CAMs were Ayurveda (32.8%) and homeopathic preparations (31.3%). The time interval between diagnosis and CAM use ranged from 1 day to 4 years. The duration of CAM use varied widely; 50.7% used CAM for < 1 month. Only 10 CAM users had HbA1C estimated during CAM use; their mean HbA1C was 12.4 ± 3.6%. Twenty-seven CAM users (40.2%) reported poorer glycemic control; 26.8% had no effect, and the rest had undefined effects due to too short duration of use.

Conclusion

CAM, mostly herbal, is frequently used among children with T1DM in North India and has detrimental effects on glycemic control. This information should be used during diabetes education to avoid medical emergencies related to sub-optimal insulin dosing.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Haliloglu B, Isguven P, Yildiz M, Arslanoglu I, Erguven M. Complementary and alternative medicine in children with type 1 diabetes mellitus. J Clin Res Pediatr Endocrinol. 2011;3(3):139–43.CrossRefPubMedPubMedCentral Haliloglu B, Isguven P, Yildiz M, Arslanoglu I, Erguven M. Complementary and alternative medicine in children with type 1 diabetes mellitus. J Clin Res Pediatr Endocrinol. 2011;3(3):139–43.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Tuomilehto J, Ogle GD, Lund-Blix NA, Stene LC. Update on worldwide trends in occurrence of childhood type 1 diabetes in 2020. Pediatr Endocrinol Rev. 2020;17(Suppl 1):198–209.PubMed Tuomilehto J, Ogle GD, Lund-Blix NA, Stene LC. Update on worldwide trends in occurrence of childhood type 1 diabetes in 2020. Pediatr Endocrinol Rev. 2020;17(Suppl 1):198–209.PubMed
5.
Zurück zum Zitat Tabish SA. Complementary and alternative healthcare: is it evidence based? INT J Health Sci (Qassim). 2008;2(1):v–ix.PubMed Tabish SA. Complementary and alternative healthcare: is it evidence based? INT J Health Sci (Qassim). 2008;2(1):v–ix.PubMed
6.
Zurück zum Zitat Posadzki P, Watson LK, Alotaibi A, Ernst E. Prevalence of use of complementary and alternative medicine (CAM) by patients/consumers in the UK: systematic review of surveys. Clin Med. 2013;13(2):126–31.CrossRef Posadzki P, Watson LK, Alotaibi A, Ernst E. Prevalence of use of complementary and alternative medicine (CAM) by patients/consumers in the UK: systematic review of surveys. Clin Med. 2013;13(2):126–31.CrossRef
7.
Zurück zum Zitat Alzahrani AS, Price MJ, Greenfield SM, Paudya LV. Global Prevalence and types of complementary and alternative medicines use amongst adults with diabetes: systematic review and meta-analysis. Eur J Clin Pharmacol. 2021;77:1259–74.CrossRefPubMedPubMedCentral Alzahrani AS, Price MJ, Greenfield SM, Paudya LV. Global Prevalence and types of complementary and alternative medicines use amongst adults with diabetes: systematic review and meta-analysis. Eur J Clin Pharmacol. 2021;77:1259–74.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Dannemann K, Hecker W, Haberland H, Herbst A, Galler A, Schäfer T, et al. Use of complementary and alternative medicine in children with type 1 diabetes mellitus—prevalence, patterns of use, and costs. Pediatr Diabetes. 2008;9(1):228–35.CrossRefPubMed Dannemann K, Hecker W, Haberland H, Herbst A, Galler A, Schäfer T, et al. Use of complementary and alternative medicine in children with type 1 diabetes mellitus—prevalence, patterns of use, and costs. Pediatr Diabetes. 2008;9(1):228–35.CrossRefPubMed
9.
Zurück zum Zitat Arykan D, Sivrikaya SK, Olgun N. Complementary alternative medicine use in children with type 1 diabetes mellitus in Erzurum. Turk J Clin Nurs. 2009;18(15):2136–44.CrossRef Arykan D, Sivrikaya SK, Olgun N. Complementary alternative medicine use in children with type 1 diabetes mellitus in Erzurum. Turk J Clin Nurs. 2009;18(15):2136–44.CrossRef
10.
Zurück zum Zitat McCarty RL, Weber WJ, Loots B, Breuner CC, Vander Stoep A, Manhart L, et al. Complementary and alternative medicine use and quality of life in pediatric diabetes. J Altern Complement Med. 2010;16(2):165–73.CrossRefPubMedPubMedCentral McCarty RL, Weber WJ, Loots B, Breuner CC, Vander Stoep A, Manhart L, et al. Complementary and alternative medicine use and quality of life in pediatric diabetes. J Altern Complement Med. 2010;16(2):165–73.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Miller JL, Binns HJ, Brickman WJ. Complementary and alternative medicine use in children with type 1 diabetes: a pilot survey of parents. Explore. 2008;4(5):311–4.CrossRefPubMed Miller JL, Binns HJ, Brickman WJ. Complementary and alternative medicine use in children with type 1 diabetes: a pilot survey of parents. Explore. 2008;4(5):311–4.CrossRefPubMed
12.
Zurück zum Zitat Bayat M, Uslu N, Erdem E, Efe YS, Variyenli N, Arican F, et al. Complementary and alternative medicine used for children with type 1 diabetes mellitus. Iran J Pediatr. 2017;27(4): e11210.CrossRef Bayat M, Uslu N, Erdem E, Efe YS, Variyenli N, Arican F, et al. Complementary and alternative medicine used for children with type 1 diabetes mellitus. Iran J Pediatr. 2017;27(4): e11210.CrossRef
13.
Zurück zum Zitat Chang HA, Wallis M, Tiralongo E. Use of complementary and alternative medicine among people with type 2 diabetes in Taiwan: a cross-sectional survey. Evid Based Complement Altern Med. 2011;2011: 983792.CrossRef Chang HA, Wallis M, Tiralongo E. Use of complementary and alternative medicine among people with type 2 diabetes in Taiwan: a cross-sectional survey. Evid Based Complement Altern Med. 2011;2011: 983792.CrossRef
14.
Zurück zum Zitat Lemay JF, Amin A, Pacaud D. Complementary and alternative medicine use in children and adolescents with type 1 diabetes. Paediatr Child Health. 2011;16(8):468–72.CrossRefPubMedPubMedCentral Lemay JF, Amin A, Pacaud D. Complementary and alternative medicine use in children and adolescents with type 1 diabetes. Paediatr Child Health. 2011;16(8):468–72.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Dhankar M. Complementary and alternative medicine: a cross-sectional observational study in pediatric inpatients. J Evid Based Integr Med. 2018;23:2515690X18765119.CrossRefPubMedPubMedCentral Dhankar M. Complementary and alternative medicine: a cross-sectional observational study in pediatric inpatients. J Evid Based Integr Med. 2018;23:2515690X18765119.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Shrilatha K, Moorthy J, Harini RR, Kaaviya AA, Sabarathinam S, Kumar SM. Prevalence and pattern of use of complementary and alternative medicine in diabetes patients in a south Indian tertiary care teaching hospital. Drug Invent Today. 2019;11(2):274–9. Shrilatha K, Moorthy J, Harini RR, Kaaviya AA, Sabarathinam S, Kumar SM. Prevalence and pattern of use of complementary and alternative medicine in diabetes patients in a south Indian tertiary care teaching hospital. Drug Invent Today. 2019;11(2):274–9.
17.
Zurück zum Zitat Vishnu N, Mini GK, Thankappan KR. Complementary and alternative medicine use by diabetes patients in Kerala. India Glob Health Epidemiol Genom. 2017;2: e6.CrossRefPubMed Vishnu N, Mini GK, Thankappan KR. Complementary and alternative medicine use by diabetes patients in Kerala. India Glob Health Epidemiol Genom. 2017;2: e6.CrossRefPubMed
18.
Zurück zum Zitat Soni V, Dayal D. Lead Toxicity due to use of traditional medicines in a child with type 1 diabetes mellitus. Indian Pediatr. 2019;56(1):77–8.PubMed Soni V, Dayal D. Lead Toxicity due to use of traditional medicines in a child with type 1 diabetes mellitus. Indian Pediatr. 2019;56(1):77–8.PubMed
19.
Zurück zum Zitat Roy K, Sharma R, Gupta P, Jain V. Severe lead toxicity due to ayurvedic medicine in a child with type 1 diabetes mellitus. Indian J Pediatr. 2022;89(1):89–90.CrossRefPubMed Roy K, Sharma R, Gupta P, Jain V. Severe lead toxicity due to ayurvedic medicine in a child with type 1 diabetes mellitus. Indian J Pediatr. 2022;89(1):89–90.CrossRefPubMed
20.
Zurück zum Zitat Kumar D, Goel NK, Pandey AK, Sarpal SS. Complementary and alternative medicine use among the cancer patients in Northern India. South Asian J Cancer. 2016;5(1):8–11.CrossRefPubMedPubMedCentral Kumar D, Goel NK, Pandey AK, Sarpal SS. Complementary and alternative medicine use among the cancer patients in Northern India. South Asian J Cancer. 2016;5(1):8–11.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Rohilla L, Gujjar N, Kaur G, Walia P, Dayal D. Financial burden for families of children with type 1 diabetes: a cross-sectional survey from North India. Diabetol Int. 2022;13(4):665–71.CrossRefPubMedPubMedCentral Rohilla L, Gujjar N, Kaur G, Walia P, Dayal D. Financial burden for families of children with type 1 diabetes: a cross-sectional survey from North India. Diabetol Int. 2022;13(4):665–71.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Kifle ZD. Prevalence and correlates of complementary and alternative medicine use among diabetic patients in a resource-limited setting. Metabol Open. 2021;10: 100095.CrossRefPubMedPubMedCentral Kifle ZD. Prevalence and correlates of complementary and alternative medicine use among diabetic patients in a resource-limited setting. Metabol Open. 2021;10: 100095.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Fabian E, Toscher S, Elmadfa I, Pieber TR. Use of complementary and alternative medicine supplements in patients with diabetes mellitus. Ann Nutr Metab. 2011;58:101–8.CrossRefPubMed Fabian E, Toscher S, Elmadfa I, Pieber TR. Use of complementary and alternative medicine supplements in patients with diabetes mellitus. Ann Nutr Metab. 2011;58:101–8.CrossRefPubMed
24.
Zurück zum Zitat Sheikhrabori A, Dehghan M, Ghaedi F, Khademi GR. Complementary and alternative medicine usage and its determinant factors among diabetic patients: an Iranian case. J Evid Based Complementary Altern Med. 2017;22(3):449–54.CrossRefPubMed Sheikhrabori A, Dehghan M, Ghaedi F, Khademi GR. Complementary and alternative medicine usage and its determinant factors among diabetic patients: an Iranian case. J Evid Based Complementary Altern Med. 2017;22(3):449–54.CrossRefPubMed
25.
Zurück zum Zitat Pumthong G, Nathason A, Tuseewan M, Pinthong P, Klangprapun S, Thepsuriyanon D, et al. Complementary and alternative medicines for diabetes mellitus management in ASEAN countries. Complement Ther Med. 2015;23:617–25.CrossRefPubMed Pumthong G, Nathason A, Tuseewan M, Pinthong P, Klangprapun S, Thepsuriyanon D, et al. Complementary and alternative medicines for diabetes mellitus management in ASEAN countries. Complement Ther Med. 2015;23:617–25.CrossRefPubMed
26.
Zurück zum Zitat Kasole R, Martin HD, Kimiywe J. Traditional medicine and its role in the management of diabetes mellitus: (patients’ and herbalists’ perspectives). Evid Based Complement Altern Med. 2019;2019:2835691.CrossRef Kasole R, Martin HD, Kimiywe J. Traditional medicine and its role in the management of diabetes mellitus: (patients’ and herbalists’ perspectives). Evid Based Complement Altern Med. 2019;2019:2835691.CrossRef
27.
Zurück zum Zitat Moravej H, Salehi A, Shamsedini A, Kolouri S, Karamizadeh Z. Complementary and alternative medicine to treat diabetes mellitus type 1 in Southern Iran. Iran J Med Sci. 2016;41(1):71–2.PubMed Moravej H, Salehi A, Shamsedini A, Kolouri S, Karamizadeh Z. Complementary and alternative medicine to treat diabetes mellitus type 1 in Southern Iran. Iran J Med Sci. 2016;41(1):71–2.PubMed
28.
Zurück zum Zitat Yeh GY, Eisenberg DM, Davis RB, Phillips RS. Use of complementary and alternative medicine among persons with diabetes mellitus: results of a National Survey. Am J Public Health. 2002;92:1648–52.CrossRefPubMedPubMedCentral Yeh GY, Eisenberg DM, Davis RB, Phillips RS. Use of complementary and alternative medicine among persons with diabetes mellitus: results of a National Survey. Am J Public Health. 2002;92:1648–52.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Rohilla L, Dayal D, Malhi P, Kaur S, Bharti B, Dhandapani M. Development and evaluation of a culturally tailored education module for type 1 diabetes in a resource-constrained setting: protocol for a mixed-methods study. Int J Clin Trials. 2021;8(3):244–52.CrossRef Rohilla L, Dayal D, Malhi P, Kaur S, Bharti B, Dhandapani M. Development and evaluation of a culturally tailored education module for type 1 diabetes in a resource-constrained setting: protocol for a mixed-methods study. Int J Clin Trials. 2021;8(3):244–52.CrossRef
30.
Zurück zum Zitat Barola A, Tiwari P, Bhansali A, Grover S, Dayal D. Cross-cultural adaptation and psychometric evaluation of Hindi version of diabetes self-management profile-self report in Indian type 1 diabetes patients. Pediatr Diabetes. 2021;22(1):101–11.CrossRefPubMed Barola A, Tiwari P, Bhansali A, Grover S, Dayal D. Cross-cultural adaptation and psychometric evaluation of Hindi version of diabetes self-management profile-self report in Indian type 1 diabetes patients. Pediatr Diabetes. 2021;22(1):101–11.CrossRefPubMed
32.
Zurück zum Zitat Rohilla L, Kaur S, Duggal M, Malhi P, Bharti B, Dayal D. Diabetes self-management education and support to improve outcomes for children and young adults with type 1 diabetes: an umbrella review of systematic reviews. Sci Diabetes Self Manag Care. 2021;47(5):332–45.CrossRefPubMed Rohilla L, Kaur S, Duggal M, Malhi P, Bharti B, Dayal D. Diabetes self-management education and support to improve outcomes for children and young adults with type 1 diabetes: an umbrella review of systematic reviews. Sci Diabetes Self Manag Care. 2021;47(5):332–45.CrossRefPubMed
33.
Zurück zum Zitat Dayal D, Yadav J, Kumar R, Gupta S, Yadav A, Nanda P. Glycaemic control and factors affecting it in type 1 diabetes in children: experience from a tertiary care centre in India. Pediatr Endocrinol Diabetes Metab. 2022;28(4):281–6.CrossRefPubMedPubMedCentral Dayal D, Yadav J, Kumar R, Gupta S, Yadav A, Nanda P. Glycaemic control and factors affecting it in type 1 diabetes in children: experience from a tertiary care centre in India. Pediatr Endocrinol Diabetes Metab. 2022;28(4):281–6.CrossRefPubMedPubMedCentral
Metadaten
Titel
Practice of complementary and alternative medicine use in North Indian children with type 1 diabetes: an exploratory study
verfasst von
Priyanka Walia
Latika Rohilla
Devi Dayal
Publikationsdatum
22.09.2023
Verlag
Springer Nature Singapore
Erschienen in
Diabetology International / Ausgabe 2/2024
Print ISSN: 2190-1678
Elektronische ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-023-00663-9

Weitere Artikel der Ausgabe 2/2024

Diabetology International 2/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

CKD bei Diabetes: Neuheiten und Zukunftsaussichten

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Jeder Mensch mit Diabetes muss auf eine chronische Nierenerkrankung gescreent werden – diese neue Empfehlung spricht die KDIGO aus. Die Therapie erfolgt individuell und je nach Szenario mit verschiedenen Substanzklassen. Künftig kommt wahrscheinlich, neben RAS-Hemmung, SGLT2-Inhibition und nsMRA, eine vierte Therapiesäule hinzu.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.